The extent of nucleotide variation within the HIV-1 env hypervariable domains serves as a marker of virus genotypes within infected individuals and as a means to track transmission of the virus between individuals. We analyzed env VI and V2 sequences in longitudinal samples from two HIV-1-infected mothers, each with three children infected by maternal transmission of the virus. Sequences in samples that were obtained from two infants at 2 d and 4 wk after birth displayed more variation in V1 and V2 than maternal samples obtained at the same times. Multiple HIV-1 genotypes were identified in each mother. In each family, multiple maternal HIV-1 genotypes were transmitted to the infants. Specific amino acid residues in the hypervariable domains were conserved within sequences from each family producing a family-specific amino acid signature pattern in V1 and V2. Viruses that were highly related to maternal viruses in signature pattern persisted for as long as 4 yr in the older children. Results support a model of transmission involving multiple HIV-1 genotypes with development of genetic variation from differential outgrowth and accumulation of genetic changes within each individual. (J. Clin. Invest. 1994. 93:380-390.) Key words: human immunodeficiency virus 1 genetic variation * maternal transmission
Introduction
Maternal transmission ofhuman immunodeficiency virus type I (HIV-1) occurs in -15 to 35% of infants born to infected women ( [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] ). Why more than two thirds of the infants born to HIV-1-infected women apparently escape infection by the virus raises important questions about virus-host interactions. Mother-to-child transmission of HIV-1 is undoubtedly multifactorial, although the factors that contribute to, or inhibit, maternal transmission of HIV-1 are not completely defined ( 11 ). Because passive maternal antibody is the primary immunity that a fetus acquires, it is likely that maternal humoral immunity is one factor in vertical transmission of HIV-1 (12) (13) (14) (15) . However, the specificities of maternal antibodies that can protect against HIV-1 transmission are unclear (16) (17) (18) (19) (20) . It is also likely that factors related to maternal virus titers, virus July 1993. tropism for different cell types, and virus variability contribute to vertical transmission.
Genetic variation within HIV-1 in vivo can have a significant impact on the biological characteristics and pathogenesis of the virus (21) (22) (23) (24) (25) . Phenotypic changes of the virus can be related directly to genetic changes that result in a high frequency of amino acid substitutions, deletions, and insertions clustered in five hypervariable domains, VI to V5, of the envencoded gp 120 molecule (26, 27) . Multiple functional determinants for virus cell tropism and host immune response map to the env hypervariable domains (28) (29) (30) (31) (32) (33) (34) (35) (36) .
Nucleotide diversification in HIV-l env hypervariable domains results in viruses that can be distinguished by genetic analyses (37) (38) (39) (40) (41) . Analyses of genetic variation primarily in the V3 domain ofenv within infected mother-infant pairs indicated that HIV-1 sequence diversity during the first 4 mo after birth was greater in samples from the mothers than from their infants (42, 43) . Because there was no evidence in either study for transmission of multiple maternal HIV-1 genotypes to the infants, it was proposed that vertical HIV-1 infection involves selective transmission of a particular maternal variant of the virus.
Our studies have focused on the genetic variability of HIV-1 over time in two different families, where neonates and their older siblings were infected by maternal transmission of the virus. The V 1 and V2 hypervariable domains of env were analyzed because previous studies demonstrated that extensive genetic variability in V1 and V2 could be used to distinguish among strains of HIV-1 (37) . The goals were to determine whether or not multiple HIV-1 genotypes were present in the mothers, to assess the possibility that multiple genotypes could be transmitted, and to evaluate the extent ofgenetic divergence over time in epidemiologically related viruses infecting different individuals.
Methods
HIV-I infected mothers and children. Samples ofperipheral blood were collected over a period of almost 2 yr from members of two families, Family A and Family B (Fig. 1) . The mothers, MA and MB, each had three infected children. Al and BI indicate the eldest child in each family; A2 and B2, the second child; A3 and B3, the youngest child. Samples are coded with numbers to represent the dates collected. In all cases, the earliest available samples were studied. In several instances, samples were collected from the mothers near the time of conception (Fig. 1 MA was identified as HIV-1 infected when Al, her 21-mo-old child, was found to have lymphoid interstitial pneumonitis, lymphadenopathy, and positive HIV-l serology. MA had no history of intravenous drug use by toxicology profile or evidence of other sexually transmitted diseases. Her risk factor was sexual contact with an intravenous drug user. MA's CD4 T-cell count fell from 587 cells/mm3 in October 1989, when she was enrolled in the study, to 38 cells/mm3 in January 1991, when zidovudine therapy was initiated. MA developed toxoplasmosis as her AIDS-defining illness in June 1991.
The mother in Family B was identified as infected by HIV-I when her oldest child, B 1, was evaluated at 9 mo ofage for lymphadenopathy and interstitial pneumonitis. Similar to mother A, MB's risk factor was a sexual partner who was an intravenous drug abuser. MB was asymptomatic with 781 CD4 cells/mm3 in January 1988. Her CD4 T-cell count dropped to 296 cells/mm3 in December 1990 and to 39 cells/ mm' in October 1991. During that time she developed HIV-associated wasting syndrome but had no opportunistic infections. Antiviral therapy was initiated after October 1991.
Each ofthe six children were full-term infants born by spontaneous vaginal delivery with normal birth histories and neonatal physical examinations. There was no clinical evidence for fetomaternal hemorrhage. Clinical profiles ofthe children are summarized in Table I . Two infants in Family A were breast fed; Al, until 11 mo of age, and A2 until 7 wk ofage. Child A l developed generalized lymphadenopathy at 14 mo and interstitial pneumonitis at 21 mo. Infant A2 developed pneumococcal meningitis at 18 wk ofage. Infant A3 was evaluated at 9 wk ofage for fever of unknown origin, oral candidiasis, and lymphadenopathy, and developed Pneumocystis carinii and cytomegalovirus pneumonia at 14 Sequences of HIV-I env VI -V2-C2 region were amplified using the PCR and nested oligonucleotide primers prepared in the DNA synthesis core facility of the Interdisciplinary Center for Biotechnology Research at the University of Florida. The outer primers were ENV5 (5'-GGTAGAACAGATGCATGAGGAT-3') and ENV6 (5'-CCA-TGTGTACATTGTACTGTGCT-3'), located at nucleotides 6102-6123 and 6544-6566 in the genome of HIVLAI (27) . The inner primers were SK 122 and SK 123 (37) . HIV (Table II ). Yet, variation within maternal sample MA.1089, obtained at the same time as infant sample A2. 1089, was 8.2% across the VI -V2-C region, reflecting variation of 22.4% in V1 and almost 12% in V2. It is unlikely that the sequence homogeneity in the infant was due to nonreplicating virus because A2 was positive for p24 antigen at both time points (see Table I ).
In contrast, samples from two infants, A3 and B3, displayed greater nucleotide sequence variation than samples obtained from their mothers at the same time (Table II) Genetic variation in VI and V2 sequences in epidemiologically unrelated viruses. The extent of variation within virus populations that were epidemiologically related in a mother and her infants led us to define the distance between epidemiologically unlinked virus populations. All V 1 and V2 amino acid sequences from the two mothers were aligned, guided by the 8 cysteine residues dispersed across the region, and the 12 conserved amino acid residues between V1 and V2 (Table III) . Because of length variation in each of the hypervariable domains, spacing was introduced to maximize alignments between the two sets of sequences.
In contrast to the C2 region, where nucleotide variability between MB and MA sequences was 9.4±2.5%, distance in the VI hypervariable domain was 30.5±4.2% and in V2, 15 .9±2.7% (Table III) . Variability in the HIV-1 sequences between the two mothers was not significantly different in some cases from the variation in HIV-1 sequences between infected members of the same family (data not shown). Yet, there was no evidence from the clinical histories of the mothers to indicate that their viruses were epidemiologically linked. The results raised the possibility that genetic variation, which evolved in V 1 and V2 over a period of several years, may be too extensive to distinguish between populations of epidemiologically related and unrelated viruses. Alternatively, there can be fea- (Table III, shadedpositions) . Only 4 signature positions were located in the conserved region C2, whereas 12 signature residues were located in the hypervariable domains, 7 in V 1 and 5 in V2. The pattern of amino acids in these positions did not predominate when V 1-V2-C2 sequences from molecular clones of HIV-1 (27) or in HIV-1 isolates (37) were analyzed (data not shown), suggesting that these residues were conserved among epidemiologically related viruses. If this were the case, then V 1-V2-C2 sequences within the infants and children in each family should contain their respective maternal signature patterns.
To examine this possibility, representative sequences from each mother were used as reference for the alignment of all sequences from her children. Significantly, the amino acid signature pattern identified in the maternal sequences was present in most sequences from all members of each family (Tables IV and V, shaded residues). The amino acid signature positions in the V 1 domain were designated 1 through 7 and those in V2, 8 through 12 . Positions in C2, designated 13 
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major genotypes were identified in both the mother and her infant A3 (Fig. 2 A, Multiple HIV-1 genotypes, particularly in Vl, were also found in the mother in Family B (Fig. 2 B (Fig. 1) .
Many of the individual Vl sequences found in the eldest child Al at 21 to 36 mo of age clustered together and, as a group, were more related to MA. 1089.2 than to other maternal variants ( Fig. 2 A, upper diagram) . One variant, A1.1089.1, was distinct both from A1 sequences in the cluster and from other MA variants. This A 1 variant may represent a virus that evolved independently in the child during the time after transmission. Alternatively, variant A1.1089.1 may reflect yet another maternal variant that was transmitted and persisted in the child.
Persistence ofHIV-1 genotypes could be detected in Family B, as well. Although there was a striking similarity in V2 sequences among all members of family B, independent of the time that had elapsed between vertical transmission and subsequent samples, V1 sequences were clearly more variable (Fig. 2  B, upper and lower diagrams) . Vl (Fig. 2 B, upper  diagram) . These maternal-child samples were collected in De- z 00 cember of 1990, when B 1 was almost 4 yr of age (Fig. 1) . (1, 3, 6, 49, 50) . The women in our study did not take zidovudine or other antiviral therapies, which might impact the frequency of vertical transmission. Two of the six children whom we studied were breast fed, but there was no evidence that they differed from the other HIV-1 infected children who were not. There were no apparent differences between other studies of vertical x transmission and ours with regard to the ages of the infants, > which ranged from birth to -4 mo, their deliveries, or their clinical presentation (42, 43 (61) (62) (63) (64) . Particular HIV-1 variants can be sequestered in other tissues, such as the lymph nodes, before emerging in PBMCs (65, 66) . Compartmentalization ofthe virus or activation of virus expression would explain the appearance of additional maternal HIV-1 genotypes in infants weeks after birth.
Timing ofvertical transmission, that is, whether the infants were infected early in gestation or near birth, cannot be determined from our studies primarily because of the persistence of maternal HIV-1 genetic variants, in some cases, throughout pregnancy. Nonetheless, studies of genetic variation in HIV-1 do provide insights into mechanisms of transmission. Because multiple maternal viruses were identified in the infants, our studies indicate that vertical HIV-1 infection is not always limited to selective transmission of a single virion or a single virus genotype. Vertical transmission could occur by cell-free virus in maternal blood if the various maternal HIV-1 genotypes were expressed (43) . Mother-to-infant transmission of HIV-1 may involve cell-associated virus, as well ( 11). In our studies, multiple HIV-1 variants detected in infants were closely related to many of the virus variants in maternal peripheral blood cells. The extent of variation in HIV-1 genotypes that can be detected in maternal cells in small volumes of peripheral blood would be sufficient to account for transmission of cell-associated virus. Maternal lymphocytes have been identified in the blood of newborns, for example, in infants with severe combined immunodeficiency disease (67) . The extent to which small numbers of maternal cells could be present in infants infected by vertical transmission ofHIV-1 remains to be examined.
Genetically related viruses persisted for a number of years within members of each family. An unexpected result was the distinct pattern of amino acid signature residues that was conserved in V 1 and V2 sequences among populations of viruses in each family. Persistence of the signature pattern independent of the overall extent of genetic variation in V1 and V2 contributed to an unambiguous fingerprint that linked epidemiologically related viruses for almost 4 yr after transmission. Results ofour studies indicate that the V I and V2 domains can be important for evaluation of the molecular epidemiology of HIV-1 transmission when the transmission link is in question.
